GLP-1s Linked to Lower Risk of Cancer Spread in Four Tumor Types

(MedPage Today) -- CHICAGO -- Use of GLP-1 receptor agonists in patients with four solid tumor types was significantly associated with lower rates of progression to metastatic disease over a 5-year period, a propensity score-matched analysis...
Source
MedPage Today
Opens original article in a new tab



